Send feedback

BRD2 p.Ala378Val

c.1133C>T · VCV4216037

Uncertain significance Single submitter
Classification
Uncertain significance
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
AlphaMissense
likely pathogenic
0.6831 · ACMG-weighted
gnomAD v4.1
Rare
ultra-rare (popmax 0.0134%, eas)
Missense predictors
1/3 damaging
AlphaMissense, REVEL, SaProt

Computational evidence

Protein change
AlphaMissense0.6831likely pathogenic
REVEL0.117moderately benign-leaning
SaProtLLR -9.17tolerated
⇒ AlphaMissense calls this damaging; REVEL and SaProt do not.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 7.7GERP 1.9, phastCons 1
Regional constrainto/e 1.05unconstrained · MANE · 3,274 bp · p 0.26 · regional, not allelic
Overall
CADD23.6PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0134% East Asian · 6/44,904 alleles
Filtering AF 0.00578% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00394%
Overall 0.00167% 27/1,613,018 alleles · ultra-rare
Ancestry group Frequency 1 in
East Asiangrpmax 0.0134% 7,484
European (non-Finnish) 0.00169% 59,002
Remaining individualsnot grpmax-eligible 0.0016% 62,476

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
BRD2
Protein
p.Ala378Val
Coding
c.1133C>T
MANE Select
NM_005104
Type
single nucleotide variant
Location
chr6:32976869 (GRCh38)
Gene constraint
LOEUF 0.28 · pLI 1.00 (gnomAD)
Structure
AlphaFold pLDDT 65.70 · 169 PDB
Residue 378
the bromo 2 domain; an α-helix
Full BRD2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/brd2-p-ala378val (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown